SONA Stock Overview
Sona Nanotech Inc. operates as a nanotechnology life sciences company.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Sona Nanotech Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.37 |
52 Week High | CA$0.56 |
52 Week Low | CA$0.14 |
Beta | -1.68 |
1 Month Change | -13.95% |
3 Month Change | 42.31% |
1 Year Change | 111.43% |
3 Year Change | -78.36% |
5 Year Change | 32.14% |
Change since IPO | 117.65% |
Recent News & Updates
Recent updates
Shareholder Returns
SONA | CA Life Sciences | CA Market | |
---|---|---|---|
7D | -11.9% | 0.08% | -0.2% |
1Y | 111.4% | 1.1% | 7.0% |
Return vs Industry: SONA exceeded the Canadian Life Sciences industry which returned 1% over the past year.
Return vs Market: SONA exceeded the Canadian Market which returned 5.3% over the past year.
Price Volatility
SONA volatility | |
---|---|
SONA Average Weekly Movement | 20.1% |
Life Sciences Industry Average Movement | 6.9% |
Market Average Movement | 8.9% |
10% most volatile stocks in CA Market | 18.2% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: SONA's share price has been volatile over the past 3 months.
Volatility Over Time: SONA's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | n/a | David Regan | www.sonanano.com |
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia therapy for cancer treatment; and nanomedical therapy for the treatment of colorectal cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; bovine TB tests; and concussion screening tests.
Sona Nanotech Inc. Fundamentals Summary
SONA fundamental statistics | |
---|---|
Market cap | CA$33.71m |
Earnings (TTM) | -CA$2.86m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-12.8x
P/E RatioIs SONA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SONA income statement (TTM) | |
---|---|
Revenue | CA$0 |
Cost of Revenue | CA$0 |
Gross Profit | CA$0 |
Other Expenses | CA$2.86m |
Earnings | -CA$2.86m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.029 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 44.6% |
How did SONA perform over the long term?
See historical performance and comparison